How Gilead Lost $7.8B in October Alone Post author:Sam Post published:November 2, 2017 Post category:BioPharma Gilead Sciences’ third-quarter financial results were dismal, to say the least. Source: BioSpace You Might Also Like Agilent Enhances Exome Sequencing For Clinical Research March 20, 2017 What You Need to Know About Fortis Therapeutics January 22, 2018 FDA Calls Omeros' Kidney Disorder Drug a Breakthrough June 12, 2017
